378 related articles for article (PubMed ID: 26436944)
1. Comparative Proteomic Analysis of Aminoglycosides Resistant and Susceptible Mycobacterium tuberculosis Clinical Isolates for Exploring Potential Drug Targets.
Sharma D; Kumar B; Lata M; Joshi B; Venkatesan K; Shukla S; Bisht D
PLoS One; 2015; 10(10):e0139414. PubMed ID: 26436944
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of Mycobacterium tuberculosis isolates resistant to kanamycin and amikacin.
Kumar B; Sharma D; Sharma P; Katoch VM; Venkatesan K; Bisht D
J Proteomics; 2013 Dec; 94():68-77. PubMed ID: 24036035
[TBL] [Abstract][Full Text] [Related]
3. M. tuberculosis ferritin (Rv3841): Potential involvement in Amikacin (AK) & Kanamycin (KM) resistance.
Sharma D; Lata M; Faheem M; Khan AU; Joshi B; Venkatesan K; Shukla S; Bisht D
Biochem Biophys Res Commun; 2016 Sep; 478(2):908-12. PubMed ID: 27521892
[TBL] [Abstract][Full Text] [Related]
4. Role of M.tuberculosis protein Rv2005c in the aminoglycosides resistance.
Sharma D; Lata M; Faheem M; Khan AU; Joshi B; Venkatesan K; Shukla S; Bisht D
Microb Pathog; 2019 Jul; 132():150-155. PubMed ID: 31059757
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of ofloxacin-mono resistant Mycobacterium tuberculosis isolates.
Lata M; Sharma D; Deo N; Tiwari PK; Bisht D; Venkatesan K
J Proteomics; 2015 Sep; 127(Pt A):114-21. PubMed ID: 26238929
[TBL] [Abstract][Full Text] [Related]
6. Interactome analysis of Rv0148 to predict potential targets and their pathways linked to aminoglycosides drug resistance: An insilico approach.
Sharma D; Singh R; Deo N; Bisht D
Microb Pathog; 2018 Aug; 121():179-183. PubMed ID: 29800702
[TBL] [Abstract][Full Text] [Related]
7. Cytosolic Proteome Profiling of Aminoglycosides Resistant
Sharma D; Lata M; Singh R; Deo N; Venkatesan K; Bisht D
Front Microbiol; 2016; 7():1816. PubMed ID: 27895634
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis.
Engström A; Perskvist N; Werngren J; Hoffner SE; Juréen P
J Antimicrob Chemother; 2011 Jun; 66(6):1247-54. PubMed ID: 21427106
[TBL] [Abstract][Full Text] [Related]
9. T cell cytokine responses in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis following stimulation with proteins purified from Mycobacterium tuberculosis MDR clinical isolates.
Hadizadeh Tasbiti A; Yari S; Ghanei M; Siadat SD; Amanzadeh A; Tabarsi P; Saeedfar K; Bahrmand A
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S132-S133. PubMed ID: 28043507
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of drug-resistant Mycobacterium tuberculosis by one-dimensional gel electrophoresis and charge chromatography.
Yari S; Hadizadeh Tasbiti A; Ghanei M; Shokrgozar MA; Fateh A; Mahdian R; Yari F; Bahrmand A
Arch Microbiol; 2017 Jan; 199(1):9-15. PubMed ID: 27417316
[TBL] [Abstract][Full Text] [Related]
11. Co-occurrence of amikacin-resistant and -susceptible Mycobacterium tuberculosis isolates in clinical samples from Beijing, China.
Zhang X; Zhao B; Huang H; Zhu Y; Peng J; Dai G; Jiang G; Liu L; Zhao Y; Jin Q
J Antimicrob Chemother; 2013 Jul; 68(7):1537-42. PubMed ID: 23539239
[TBL] [Abstract][Full Text] [Related]
12. Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis.
Krüüner A; Jureen P; Levina K; Ghebremichael S; Hoffner S
Antimicrob Agents Chemother; 2003 Sep; 47(9):2971-3. PubMed ID: 12937004
[TBL] [Abstract][Full Text] [Related]
13. eis Promoter C14G and C15G Mutations Do Not Confer Kanamycin Resistance in Mycobacterium tuberculosis.
Pholwat S; Stroup S; Heysell S; Ogarkov O; Zhdanova S; Ramakrishnan G; Houpt E
Antimicrob Agents Chemother; 2016 Dec; 60(12):7522-7523. PubMed ID: 27736762
[TBL] [Abstract][Full Text] [Related]
14. Protein-protein interaction of Rv0148 with Htdy and its predicted role towards drug resistance in Mycobacterium tuberculosis.
Bhargavi G; Hassan S; Balaji S; Tripathy SP; Palaniyandi K
BMC Microbiol; 2020 Apr; 20(1):93. PubMed ID: 32295519
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China.
Du Q; Dai G; Long Q; Yu X; Dong L; Huang H; Xie J
Diagn Microbiol Infect Dis; 2013 Oct; 77(2):138-42. PubMed ID: 23948547
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis.
Alangaden GJ; Kreiswirth BN; Aouad A; Khetarpal M; Igno FR; Moghazeh SL; Manavathu EK; Lerner SA
Antimicrob Agents Chemother; 1998 May; 42(5):1295-7. PubMed ID: 9593173
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of the proteomes of isoniazid-resistant Mycobacterium tuberculosis strains and isoniazid-susceptible strains].
Jiang X; Gao F; Zhang WH; Hu ZY; Wang HH
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):427-31. PubMed ID: 17673015
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis.
Zaunbrecher MA; Sikes RD; Metchock B; Shinnick TM; Posey JE
Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20004-9. PubMed ID: 19906990
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain.
Sowajassatakul A; Prammananan T; Chaiprasert A; Phunpruch S
Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):33. PubMed ID: 30008266
[TBL] [Abstract][Full Text] [Related]
20. Cross-resistance of Mycobacterium tuberculosis isolates among streptomycin, kanamycin and amikacin.
Sugawara I; Zhang J; Li C
Indian J Exp Biol; 2009 Jun; 47(6):520-2. PubMed ID: 19634718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
